Importance of restrictions
Restrictions are a tool to protect human health and the environment from unacceptable risks posed by some chemicals. Restrictions, described in Annex XVII of regulation 1907/2006 (REACH), may limit or ban the manufacture, placing on the market or use of a substance. Restrictions to which substances are potentially subjected have to be reported in Section 15 of the SDS.
What are the modifications brought to Annex XVII by the new Regulation?
EU regulation 2017/1510 updates the lists of carcinogenic, mutagenic or reproductive toxicant (CMR) substances contained in Annex XVII of REACH. This regulation, published in the Official Journal of the European Union on August 30th 2017, will enter into force on September 20th 2017. Starting from this date, the following substances, classified as reproductive toxicant category 1B, will be subjected to restriction:
- tetrahydrofurfuryl alcohol (CAS: 97-99-4),
- gallium arsenide (CAS: 1303-00-0),
- tributyltin compounds (with the exception of those specified elsewhere in Annex XVII),
- 1,2-benzenedicarboxylic acid (CAS: 68515-50-4),
- imidazole (CAS: 288-32-4),
- flumioxazin (ISO) (CAS: 103361-09-7).
Moreover, the same regulation establishes the modification of the entry relating to warfarin (CAS: 81-81-2, 5543-57-7, 5543-58-8) and the inclusion of other substances in Annex XVII of REACH. Among them it is worth remembering, as an example, the following substances:
- 1,2-dichloropropane (CAS: 78-87-5),
- lead powder and lead massive (CAS: 7439-92-1),
- bisphenol A (CAS: 80-05-7).
Nevertheless, the restriction for these substances will apply starting from March 1st 2018. The complete list of substances subjected to restriction is available by consulting the text of the regulation 2017/1510 itself.
Restrictions that apply to all the substances listed in regulation 2017/1510 are those established by points 28, 29 and 30 of Annex XVII of REACH. They prohibit the placing on the market and the use for supply to the general public of those substances (and mixtures containing them) classified as CMR category 1A or 1B that are listed in the appendices of Annex XVII, if their concentrations are greater than those specified.
Thus, suppliers shall ensure before the placing on the market that the packaging of such substances and mixtures is marked visibly, legibly and indelibly as follows: ‘Restricted to professional users’.
As a result of the entry into force of regulation 2017/1510, Selerant is already working to provide the updating of these data.
For more information concerning regulation 2017/1510 amending restrictions of Annex XVII, follow this link: